These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
62. A mutation threshold distinguishes the antitumorigenic effects of the mitochondrial gene MTND1, an oncojanus function. Gasparre G; Kurelac I; Capristo M; Iommarini L; Ghelli A; Ceccarelli C; Nicoletti G; Nanni P; De Giovanni C; Scotlandi K; Betts CM; Carelli V; Lollini PL; Romeo G; Rugolo M; Porcelli AM Cancer Res; 2011 Oct; 71(19):6220-9. PubMed ID: 21852384 [TBL] [Abstract][Full Text] [Related]
63. Respiratory complex I is essential to induce a Warburg profile in mitochondria-defective tumor cells. Calabrese C; Iommarini L; Kurelac I; Calvaruso MA; Capristo M; Lollini PL; Nanni P; Bergamini C; Nicoletti G; Giovanni CD; Ghelli A; Giorgio V; Caratozzolo MF; Marzano F; Manzari C; Betts CM; Carelli V; Ceccarelli C; Attimonelli M; Romeo G; Fato R; Rugolo M; Tullo A; Gasparre G; Porcelli AM Cancer Metab; 2013 Mar; 1(1):11. PubMed ID: 24280190 [TBL] [Abstract][Full Text] [Related]
64. Different mtDNA mutations modify tumor progression in dependence of the degree of respiratory complex I impairment. Iommarini L; Kurelac I; Capristo M; Calvaruso MA; Giorgio V; Bergamini C; Ghelli A; Nanni P; De Giovanni C; Carelli V; Fato R; Lollini PL; Rugolo M; Gasparre G; Porcelli AM Hum Mol Genet; 2014 Mar; 23(6):1453-66. PubMed ID: 24163135 [TBL] [Abstract][Full Text] [Related]
65. Recurrent tissue-specific mtDNA mutations are common in humans. Samuels DC; Li C; Li B; Song Z; Torstenson E; Boyd Clay H; Rokas A; Thornton-Wells TA; Moore JH; Hughes TM; Hoffman RD; Haines JL; Murdock DG; Mortlock DP; Williams SM PLoS Genet; 2013 Nov; 9(11):e1003929. PubMed ID: 24244193 [TBL] [Abstract][Full Text] [Related]
66. Molecular and metabolic features of oncocytomas: Seeking the blueprints of indolent cancers. De Luise M; Girolimetti G; Okere B; Porcelli AM; Kurelac I; Gasparre G Biochim Biophys Acta Bioenerg; 2017 Aug; 1858(8):591-601. PubMed ID: 28115060 [TBL] [Abstract][Full Text] [Related]
67. Roles of MT-ND1 in Cancer. Xu YC; Su J; Zhou JJ; Yuan Q; Han JS Curr Med Sci; 2023 Oct; 43(5):869-878. PubMed ID: 37642864 [TBL] [Abstract][Full Text] [Related]
68. Delivery Systems for Mitochondrial Gene Therapy: A Review. Faria R; Boisguérin P; Sousa Â; Costa D Pharmaceutics; 2023 Feb; 15(2):. PubMed ID: 36839894 [TBL] [Abstract][Full Text] [Related]
69. Reprogramming of Cellular Metabolism and Its Therapeutic Applications in Thyroid Cancer. Nagayama Y; Hamada K Metabolites; 2022 Dec; 12(12):. PubMed ID: 36557253 [TBL] [Abstract][Full Text] [Related]
70. MIEAP and ATG5 are tumor suppressors in a mouse model of BRAF Hamada K; Kurashige T; Shimamura M; Arakawa H; Nakamura Y; Nagayama Y Front Endocrinol (Lausanne); 2022; 13():932754. PubMed ID: 36187114 [TBL] [Abstract][Full Text] [Related]
71. Oncocytic lesions of the ocular adnexa: A review of the histopathology with a brief discussion of the pathogenesis. Heathcote JG; Archibald CW; Valenzuela AA Saudi J Ophthalmol; 2021; 35(3):179-185. PubMed ID: 35601848 [TBL] [Abstract][Full Text] [Related]
72. Pathogenic Mitochondrial DNA Mutation Load Inversely Correlates with Malignant Features in Familial Oncocytic Parathyroid Tumors Associated with Hyperparathyroidism-Jaw Tumor Syndrome. De Luise M; Iommarini L; Marchio L; Tedesco G; Coadă CA; Repaci A; Turchetti D; Tardio ML; Salfi N; Pagotto U; Kurelac I; Porcelli AM; Gasparre G Cells; 2021 Oct; 10(11):. PubMed ID: 34831144 [TBL] [Abstract][Full Text] [Related]
73. Papillary thyroid carcinoma tall cell variant shares accumulation of mitochondria, mitochondrial DNA mutations, and loss of oxidative phosphorylation complex I integrity with oncocytic tumors. Tsybrovskyy O; De Luise M; de Biase D; Caporali L; Fiorini C; Gasparre G; Carelli V; Hackl D; Imamovic L; Haim S; Sobrinho-Simões M; Tallini G J Pathol Clin Res; 2022 Mar; 8(2):155-168. PubMed ID: 34792302 [TBL] [Abstract][Full Text] [Related]
74. Respiratory Complex I dysfunction in cancer: from a maze of cellular adaptive responses to potential therapeutic strategies. Sollazzo M; De Luise M; Lemma S; Bressi L; Iorio M; Miglietta S; Milioni S; Kurelac I; Iommarini L; Gasparre G; Porcelli AM FEBS J; 2022 Dec; 289(24):8003-8019. PubMed ID: 34606156 [TBL] [Abstract][Full Text] [Related]
75. Downregulation of miR-181b-5p Inhibits the Viability, Migration, and Glycolysis of Gallbladder Cancer by Upregulating PDHX Under Hypoxia. Qin Y; Zheng Y; Huang C; Li Y; Gu M; Wu Q Front Oncol; 2021; 11():683725. PubMed ID: 34485121 [TBL] [Abstract][Full Text] [Related]
76. NDUFS3 depletion permits complex I maturation and reveals TMEM126A/OPA7 as an assembly factor binding the ND4-module intermediate. D'Angelo L; Astro E; De Luise M; Kurelac I; Umesh-Ganesh N; Ding S; Fearnley IM; Gasparre G; Zeviani M; Porcelli AM; Fernandez-Vizarra E; Iommarini L Cell Rep; 2021 Apr; 35(3):109002. PubMed ID: 33882309 [TBL] [Abstract][Full Text] [Related]
78. A human pluripotent stem cell model for the analysis of metabolic dysfunction in hepatic steatosis. Sinton MC; Meseguer-Ripolles J; Lucendo-Villarin B; Wernig-Zorc S; Thomson JP; Carter RN; Lyall MJ; Walker PD; Thakker A; Meehan RR; Lavery GG; Morton NM; Ludwig C; Tennant DA; Hay DC; Drake AJ iScience; 2021 Jan; 24(1):101931. PubMed ID: 33409477 [TBL] [Abstract][Full Text] [Related]
79. Causative role for defective expression of mitochondria-eating protein in accumulation of mitochondria in thyroid oncocytic cell tumors. Mussazhanova Z; Shimamura M; Kurashige T; Ito M; Nakashima M; Nagayama Y Cancer Sci; 2020 Aug; 111(8):2814-2823. PubMed ID: 32458504 [TBL] [Abstract][Full Text] [Related]
80. Metabolic Plasticity in Chemotherapy Resistance. Desbats MA; Giacomini I; Prayer-Galetti T; Montopoli M Front Oncol; 2020; 10():281. PubMed ID: 32211323 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]